MEA also said that India is awaiting confirmation of necessary regulatory clearances from Sri Lanka, Afghanistan and Mauritius for supply of the vaccines

The Indian government Tuesday said that it has received several requests from neighbouring counties for the supply of Indian manufactured Covid-19 vaccines. Following the request, the government announced that it will supply COVID-19 vaccines under grant assistance to Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles from Wednesday.

The Ministry of External Affairs said India will supply COVID-19 vaccines to partner countries over the coming weeks and months in a phased manner keeping in view the domestic requirements.

"Domestic manufacturers will have adequate stocks to meet domestic requirements while supplying abroad," the ministry said.

The ministry also said that India is awaiting confirmation of necessary regulatory clearances from Sri Lanka, Afghanistan and Mauritius for supply of the vaccines.

Prime Minister Narendra Modi expressed his admiration in India's efforts in the field of healthcare needs of the global community. Taking to twitter, he said, "India is deeply honoured to be a long-trusted partner in meeting the healthcare needs of the global community. Supplies of COVID vaccines to several countries will commence tomorrow, and more will follow in the days ahead."

India is deeply honoured to be a long-trusted partner in meeting the healthcare needs of the global community. Supplies of Covid vaccines to several countries will commence tomorrow, and more will follow in the days ahead. #VaccineMaitri https://t.co/9Czfkuk8h7

The Indian government Tuesday said that it has received several requests from neighbouring counties for the supply of Indian manufactured Covid-19 vaccines. Following the request, the government announced that it will supply COVID-19 vaccines under grant assistance to Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles from Wednesday.

The Ministry of External Affairs said India will supply COVID-19 vaccines to partner countries over the coming weeks and months in a phased manner keeping in view the domestic requirements.

"Domestic manufacturers will have adequate stocks to meet domestic requirements while supplying abroad," the ministry said.

The ministry also said that India is awaiting confirmation of necessary regulatory clearances from Sri Lanka, Afghanistan and Mauritius for supply of the vaccines.

Prime Minister Narendra Modi expressed his admiration in India's efforts in the field of healthcare needs of the global community. Taking to twitter, he said, "India is deeply honoured to be a long-trusted partner in meeting the healthcare needs of the global community. Supplies of COVID vaccines to several countries will commence tomorrow, and more will follow in the days ahead."

In a statement, the MEA said India has received several requests for the supply of Indian-manufactured vaccines from neighbouring and key partner countries.

"In response to these requests, and in keeping with India's stated commitment to use India's vaccine production and delivery capacity to help all of humanity fight the COVID pandemic, supplies under grant assistance to Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles will begin from January 20," it said.

"In respect of Sri Lanka, Afghanistan and Mauritius, we are awaiting their confirmation of necessary regulatory clearances," it added.

India has already rolled out a massive coronavirus vaccination drive under which two vaccines, Covishield and Covaxin, are being administered to frontline health workers across the country.

Prime Minister Narendra Modi on Saturday launched the vaccination programme covering the entire length and breadth of the country and urged people to show patience during the COVID-19 immunisation drive as they had shown till now in fighting the pandemic.

The Drugs Controller General of India (DCGI) had earlier this month approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country.

According to the government, the shots will be offered first to an estimated one crore healthcare workers and around two crore frontline workers, and then to persons above 50 years of age, followed by persons younger than 50 years of age with associated comorbidities.

As of today, a total of 4,54,049 beneficiaries have so far been vaccinated against COVID-19 in the country, which is more than double the number of coronavirus active cases, the Union Health Ministry said.

Click here to read the Mint ePaperMint is now on Telegram. Join Mint channel in your Telegram and stay updated with the latest business news.

Log in to our website to save your bookmarks. It'll just take a moment.

Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.

Your session has expired, please login again.

You are now subscribed to our newsletters. In case you can’t find any email from our side, please check the spam folder.